vs
Bioceres Crop Solutions Corp.（BIOX）与Cibus, Inc.（CBUS）财务数据对比。点击上方公司名可切换其他公司
Bioceres Crop Solutions Corp.的季度营收约是Cibus, Inc.的73.4倍（$77.6M vs $1.1M）。Bioceres Crop Solutions Corp.净利率更高（-9.6% vs -2959.9%，领先2950.3%）。Cibus, Inc.同比增速更快（-12.8% vs -16.8%）。过去两年Cibus, Inc.的营收复合增速更高（39.3% vs -8.4%）
Bioceres Crop Solutions Corp是一家全球农业科技企业，研发并商业化耐旱种子性状、生物肥料、生物农药等可持续作物增产解决方案，服务南美、北美、欧洲及亚太地区的农户，致力于提升作物产量，同时降低农业生产的环境影响。
Cibus Inc.是一家领先的农业生物技术企业，专注于利用精准基因编辑技术开发可持续的优质作物性状，涵盖抗除草剂、抗病抗虫、产量提升等解决方案，服务全球农业市场、种子生产商及种植群体，助力降低农业生产环境负担，提高生产效率。
BIOX vs CBUS — 直观对比
营收规模更大
BIOX
是对方的73.4倍
$1.1M
营收增速更快
CBUS
高出4.0%
-16.8%
净利率更高
BIOX
高出2950.3%
-2959.9%
两年增速更快
CBUS
近两年复合增速
-8.4%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $77.6M | $1.1M |
| 净利润 | $-7.4M | $-31.3M |
| 毛利率 | 46.8% | — |
| 营业利润率 | 9.3% | -2135.7% |
| 净利率 | -9.6% | -2959.9% |
| 营收同比 | -16.8% | -12.8% |
| 净利润同比 | -20.2% | -35.4% |
| 每股收益（稀释后） | $-0.12 | $-0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIOXCBUS
| Q4 25 | — | $1.1M | ||
| Q3 25 | $77.6M | $615.0K | ||
| Q2 25 | — | $933.0K | ||
| Q1 25 | $60.6M | $1.0M | ||
| Q4 24 | $98.8M | $1.2M | ||
| Q3 24 | $93.3M | $1.7M | ||
| Q2 24 | — | $838.0K | ||
| Q1 24 | $84.0M | $545.0K |
净利润BIOXCBUS
| Q4 25 | — | $-31.3M | ||
| Q3 25 | $-7.4M | $-23.5M | ||
| Q2 25 | — | $-25.4M | ||
| Q1 25 | $-1.6M | $-46.9M | ||
| Q4 24 | $605.2K | $-23.1M | ||
| Q3 24 | $-6.2M | $-180.0M | ||
| Q2 24 | — | $-24.9M | ||
| Q1 24 | $9.8M | $-23.4M |
毛利率BIOXCBUS
| Q4 25 | — | — | ||
| Q3 25 | 46.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 39.4% | — | ||
| Q4 24 | 42.0% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 50.8% | — |
营业利润率BIOXCBUS
| Q4 25 | — | -2135.7% | ||
| Q3 25 | 9.3% | -2510.2% | ||
| Q2 25 | — | -1923.5% | ||
| Q1 25 | 1.5% | -4020.4% | ||
| Q4 24 | 14.5% | -1487.1% | ||
| Q3 24 | 2.5% | -12023.8% | ||
| Q2 24 | — | -2563.5% | ||
| Q1 24 | 15.7% | -3385.9% |
净利率BIOXCBUS
| Q4 25 | — | -2959.9% | ||
| Q3 25 | -9.6% | -3827.8% | ||
| Q2 25 | — | -2719.4% | ||
| Q1 25 | -2.6% | -4534.4% | ||
| Q4 24 | 0.6% | -1906.1% | ||
| Q3 24 | -6.6% | -10795.9% | ||
| Q2 24 | — | -2969.3% | ||
| Q1 24 | 11.6% | -4300.0% |
每股收益（稀释后）BIOXCBUS
| Q4 25 | — | $-0.39 | ||
| Q3 25 | $-0.12 | $-0.44 | ||
| Q2 25 | — | $-0.61 | ||
| Q1 25 | $-0.02 | $-1.34 | ||
| Q4 24 | $0.00 | $-0.94 | ||
| Q3 24 | $-0.10 | $-7.63 | ||
| Q2 24 | — | $-1.14 | ||
| Q1 24 | $0.14 | $-1.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.5M | $9.9M |
| 总债务越低越好 | — | $528.0K |
| 股东权益账面价值 | $288.3M | $21.8M |
| 总资产 | $734.9M | $305.0M |
| 负债/权益比越低杠杆越低 | — | 0.02× |
8季度趋势，按日历期对齐
现金及短期投资BIOXCBUS
| Q4 25 | — | $9.9M | ||
| Q3 25 | $15.5M | $23.9M | ||
| Q2 25 | — | $36.5M | ||
| Q1 25 | $38.5M | $23.6M | ||
| Q4 24 | $29.2M | $14.4M | ||
| Q3 24 | $32.3M | $28.8M | ||
| Q2 24 | — | $30.0M | ||
| Q1 24 | $16.4M | $24.5M |
总债务BIOXCBUS
| Q4 25 | — | $528.0K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $662.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BIOXCBUS
| Q4 25 | — | $21.8M | ||
| Q3 25 | $288.3M | $50.4M | ||
| Q2 25 | — | $72.1M | ||
| Q1 25 | $345.0M | $70.3M | ||
| Q4 24 | $346.3M | $92.2M | ||
| Q3 24 | $346.0M | $108.1M | ||
| Q2 24 | — | $270.5M | ||
| Q1 24 | $348.5M | $278.2M |
总资产BIOXCBUS
| Q4 25 | — | $305.0M | ||
| Q3 25 | $734.9M | $330.2M | ||
| Q2 25 | — | $346.2M | ||
| Q1 25 | $798.2M | $335.0M | ||
| Q4 24 | $835.2M | $350.1M | ||
| Q3 24 | $827.3M | $367.9M | ||
| Q2 24 | — | $553.4M | ||
| Q1 24 | $836.1M | $533.0M |
负债/权益比BIOXCBUS
| Q4 25 | — | 0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-13.4M |
| 自由现金流经营现金流 - 资本支出 | — | $-13.5M |
| 自由现金流率自由现金流/营收 | — | -1277.8% |
| 资本支出强度资本支出/营收 | — | 8.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-51.2M |
8季度趋势，按日历期对齐
经营现金流BIOXCBUS
| Q4 25 | — | $-13.4M | ||
| Q3 25 | $14.4M | $-11.7M | ||
| Q2 25 | — | $-13.6M | ||
| Q1 25 | $23.3M | $-11.8M | ||
| Q4 24 | $-5.4M | $-14.0M | ||
| Q3 24 | $5.2M | $-13.5M | ||
| Q2 24 | — | $-17.0M | ||
| Q1 24 | $-17.4M | $-13.5M |
自由现金流BIOXCBUS
| Q4 25 | — | $-13.5M | ||
| Q3 25 | — | $-11.8M | ||
| Q2 25 | — | $-13.7M | ||
| Q1 25 | — | $-12.1M | ||
| Q4 24 | — | $-14.1M | ||
| Q3 24 | — | $-13.9M | ||
| Q2 24 | — | $-17.2M | ||
| Q1 24 | — | $-13.7M |
自由现金流率BIOXCBUS
| Q4 25 | — | -1277.8% | ||
| Q3 25 | — | -1926.5% | ||
| Q2 25 | — | -1468.1% | ||
| Q1 25 | — | -1172.0% | ||
| Q4 24 | — | -1159.3% | ||
| Q3 24 | — | -832.3% | ||
| Q2 24 | — | -2054.5% | ||
| Q1 24 | — | -2515.2% |
资本支出强度BIOXCBUS
| Q4 25 | — | 8.1% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 10.0% | ||
| Q1 25 | — | 28.1% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | — | 21.3% | ||
| Q2 24 | — | 20.2% | ||
| Q1 24 | — | 41.8% |
现金转化率BIOXCBUS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -8.85× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.78× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
